# Gemini Pharmaceuticals, Inc., Commack, NY – FDA Inspections Source: https://www.keypedia.com/companies/gemini-pharmaceuticals-inc/9e83f65c-3863-4ad6-a434-b37d9673ac0f > Inspection records and compliance data for Gemini Pharmaceuticals, Inc. in Commack, New York. 10 FDA inspections on record, 2 Form 483s, last inspected May 15, 2026. --- ## Details - Name: Gemini Pharmaceuticals, Inc. - FEI Number: 2432926 - Address Line 1: 87 Modular Ave - City: Commack - State: New York - Zip Code: 11725 - Country Name: United States - Address: 87 Modular Ave, Commack, New York 11725, United States - Country: United States ## Related Documents - [FDA Inspection 1317530 - Gemini Pharmaceuticals, Inc. - 2026-05-15](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/3c2276f9-a20a-4803-a2e7-9277b1bf2a74) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 15, 2026 - [483 - Gemini Pharmaceuticals, Inc. - 2022-07-26](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/ece92446-1406-489e-aeac-8758665dd9f7) — source: FDA, date: July 26, 2022 - FDA Inspection 1175407 - Gemini Pharmaceuticals, Inc. - 2022-07-26 — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2022 - FDA Inspection 1175407 - Gemini Pharmaceuticals, Inc. - 2022-07-26 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2022 - FDA Inspection 1064447 - Gemini Pharmaceuticals, Inc. - 2018-08-23 — classification: No Action Indicated (NAI), source: FDA, date: August 23, 2018 - [EIR - Gemini Pharmaceuticals, Inc. - 2018-02-16](https://www.keypedia.com/records/eir/gemini-pharmaceuticals-inc/1b754bc1-a15c-414b-aeeb-a97dddcbb36c) — source: FDA, date: February 16, 2018 - [483 - Gemini Pharmaceuticals, Inc. - 2018-02-16](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/563a968e-94b3-45dd-b4f5-b8039e638982) — source: FDA, date: February 16, 2018 - [FDA Inspection 1041525 - Gemini Pharmaceuticals, Inc. - 2018-02-16](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/5f815dde-5720-44ae-a6e5-ab350f64a85e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 16, 2018 - [EIR - Gemini Pharmaceuticals, Inc. - 2015-06-30](https://www.keypedia.com/records/eir/gemini-pharmaceuticals-inc/8b9c0f66-00ab-4cd3-88f2-b473544da1a7) — source: FDA, date: June 30, 2015 - [483 - Gemini Pharmaceuticals, Inc. - 2015-06-30](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/355d3e31-f50a-4ffb-8c27-5cb4b6411eb3) — source: FDA, date: June 30, 2015 - [FDA Inspection 936886 - Gemini Pharmaceuticals, Inc. - 2015-06-30](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/6d577591-8391-4524-a2b4-21427df5636b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2015 - [FDA Inspection 856101 - Gemini Pharmaceuticals, Inc. - 2013-11-08](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/a0e9984c-d1de-458a-8f0d-9838d2949911) — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2013 - FDA Inspection 856101 - Gemini Pharmaceuticals, Inc. - 2013-11-08 — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2013 - [FDA Inspection 804876 - Gemini Pharmaceuticals, Inc. - 2012-09-07](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/8ccd38c4-b04f-4a2f-a1ab-040379671397) — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2012 - [EIR - Gemini Pharmaceuticals, Inc. - 2011-06-01](https://www.keypedia.com/records/eir/gemini-pharmaceuticals-inc/1cffccbc-7f16-4c74-a844-b67a5fe725ba) — source: FDA, date: June 1, 2011 - [483 - Gemini Pharmaceuticals, Inc. - 2011-06-01](https://www.keypedia.com/records/483/gemini-pharmaceuticals-inc/d3335f63-f681-4529-a490-7f5be013903e) — source: FDA, date: June 1, 2011 - [FDA Inspection 726235 - Gemini Pharmaceuticals, Inc. - 2011-06-01](https://www.keypedia.com/records/fda_inspections/gemini-pharmaceuticals-inc/36e1597c-1447-4a34-be98-ec5dcbc2deb5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2011 - [EIR - Gemini Pharmaceuticals, Inc. - 2010-03-23](https://www.keypedia.com/records/eir/gemini-pharmaceuticals-inc/2a6f3f3e-9c39-474a-a005-1e8d8500073e) — source: FDA, date: March 23, 2010 - [EIR - Gemini Pharmaceuticals, Inc. - 2009-02-05](https://www.keypedia.com/records/eir/gemini-pharmaceuticals-inc/3279d636-5970-47f7-8c7a-7260f6323fea) — source: FDA, date: February 5, 2009 ## Related Companies - [Wasatch Product Development, LLC](https://www.keypedia.com/companies/wasatch-product-development-llc/3545661f-a68f-404a-895d-c00555648648) - [Exquisite Corporation](https://www.keypedia.com/companies/exquisite-corporation/cf4dd029-0549-4ddb-b1f4-83e7a2559f7c) - [TAKA USA, INC.](https://www.keypedia.com/companies/taka-usa-inc/b5688fbb-faaa-4716-93f5-37cce7b85f23) - [Absolutely Natural](https://www.keypedia.com/companies/absolutely-natural/cb6a7d5c-99b4-4103-b94c-d93d9c0aa2ba) - [PhytogenX, Inc.](https://www.keypedia.com/companies/phytogenx-inc/d1defb06-8ec1-4a7f-8617-7e210e28da3a) - [Sklar BOV Solutions, Inc.](https://www.keypedia.com/companies/sklar-bov-solutions-inc/bb3c6506-3c30-482d-86a7-4f421dba8efa) - [Machine & Welding Supply Company](https://www.keypedia.com/companies/machine-welding-supply-company/1884aa32-ac32-4623-9d14-600e56ec4b39) - [Amol Pharmaceuticals Private Ltd.](https://www.keypedia.com/companies/amol-pharmaceuticals-private-ltd/25109535-73e8-434b-98f1-01695cc33434) - [BioLyte Laboratories, LLC](https://www.keypedia.com/companies/biolyte-laboratories-llc/72aab89c-4774-4dcb-9daa-42d74b544922) - [Nature's Innovation, Inc.](https://www.keypedia.com/companies/natures-innovation-inc/d23f0b20-5c24-4907-9271-9bea780b0809) ## Related Officers - [investigator](https://www.keypedia.com/people/deborah-j-parris/0763ef7f-992d-412b-8497-4539ed851c03) - [recipient](https://www.keypedia.com/people/mike-andrew-finamore/103ee1c1-0ef0-48ac-898f-5f305b2c44ea) - [recipient](https://www.keypedia.com/people/michael-finamore/82dc9fbf-a474-4744-b219-2e22fe1a8523) - [Consumer Safety Officer at FDA](https://www.keypedia.com/people/alice-s-tsao/b6d72ceb-de7c-413d-b104-cac3b075c170) - [investigator](https://www.keypedia.com/people/thomas-j-mooney/160b0a9e-fd07-48a7-af19-ccf648449bdc) - [company_representative](https://www.keypedia.com/people/andrew-a-finamore/674800e2-39e9-4b38-927d-9419734fd17d)